نتائج البحث - "Non-Small-Cell Lung/pathology"

1

دورية أكاديمية

Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence.

المؤلفون: LOUIS, Thomas, Lucia, François, Cousin, François, MIEVIS, Carole, Jansen, Nicolas, Duysinx, Bernard, Le Pennec, Romain, Visvikis, Dimitris, Nebbache, Malik, Rehn, Martin, Hamya, Mohamed, Geier, Margaux, Salaun, Pierre-Yves, Schick, Ulrike, Hatt, Mathieu, Coucke, Philippe, Lovinfosse, Pierre, Hustinx, Roland

المصدر: Scientific Reports, 14 (1), 9028 (2024-04-19)

مصطلحات موضوعية: Humans, Radiomics, Tomography, X-Ray Computed, Lung Neoplasms/diagnostic imaging, Lung Neoplasms/radiotherapy, Lung Neoplasms/pathology, Carcinoma, Non-Small-Cell Lung/diagnostic imaging, Carcinoma, Non-Small-Cell Lung/radiotherapy, Carcinoma, Non-Small-Cell Lung/pathology, Radiosurgery/methods, Small Cell Lung Carcinoma, Multidisciplinary, Human health sciences, Radiology, nuclear medicine & imaging, Sciences de la santé humaine, Radiologie, médecine & imagerie nucléaire

العلاقة: https://www.nature.com/articles/s41598-024-58551-4.pdfTest; 10.1038/s41598-024-58551-4; urn:issn:2045-2322

الوصول الحر: https://orbi.uliege.be/handle/2268/318575Test

View record in ORBi

2

دورية أكاديمية

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

المساهمون: G Galffy, I Lugowska, E V Poddubskaya, B C Cho, M-J Ahn, J-Y Han, W-C Su, R J Hauke, S H Dyar, D H Lee, P Serwatowski, D L Estelles, V R Holden, Y J Kim, V Vladimirov, Z Horvath, A Ghose, A Goldman, A di Pietro, J Wang, D A Murphy, A Alhadab, M Laskov, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal / adverse effects, Axitinib / pharmacology, Axitinib / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / pathology, Transitional Cell, Cisplatin / pharmacology, Cisplatin / therapeutic use, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / pathology, Urinary Bladder Neoplasms, avelumab plus axitinib, immune checkpoint inhibitor, non-small-cell lung cancer, urothelial carcinoma

العلاقة: ESMO OPEN; J03799; OAK-2023-02583; https://ir.ymlib.yonsei.ac.kr/handle/22282913/196061Test; T202304518; ESMO OPEN, Vol.8(3) : 101173, 2023-06

الإتاحة: https://doi.org/10.1016/j.esmoop.2023.101173Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/196061Test

View record in BASE

النص الكامل

3

دورية أكاديمية

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

المساهمون: Tetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, Myung-Ju Ahn, Ullas Batra, Byoung-Chul Cho, Gerardo Cornelio, Tony Lim, Tony Mok, Kumar Prabhash, Thanyanan Reungwetwattana, Sheng-Xiang Ren, Navneet Singh, Shinichi Toyooka, Yi-Long Wu, Pan-Chyr Yang, Yasushi Yatabe, Cho, Byoung Chul

مصطلحات موضوعية: Asia / epidemiology, Biomarkers, Tumor / genetics, Carcinoma, Non-Small-Cell Lung* / pathology, Consensus, ErbB Receptors / genetics, Humans, Lung Neoplasms* / pathology, Mutation, Protein-Tyrosine Kinases / genetics, Proto-Oncogene Proteins / genetics, Adenocarcinoma, Liquid biopsy, Non–small cell lung cancer, Squamous carcinoma, ctDNA

العلاقة: JOURNAL OF THORACIC ONCOLOGY; J01909; OAK-2023-02582; https://ir.ymlib.yonsei.ac.kr/handle/22282913/196060Test; https://www.sciencedirect.com/science/article/pii/S1556086422019050Test; T202304517; JOURNAL OF THORACIC ONCOLOGY, Vol.18(4) : 436-446, 2023-04

الإتاحة: https://doi.org/10.1016/j.jtho.2022.10.021Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/196060Test
https://www.sciencedirect.com/science/article/pii/S1556086422019050Test

View record in BASE

النص الكامل

4

دورية أكاديمية

Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study

المساهمون: Hyunwook Kim, Beung-Chul Ahn, Jiyun Lee, Jii Bum Lee, Min-Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim, Kim, Hyun Wook

مصطلحات موضوعية: Aniline Compounds / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, ErbB Receptors / genetics, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mutation / genetics, Protein Kinase Inhibitors / pharmacology, Lazertinib, Non-small cell lung cancer, Real-world data, T790M EGFR mutation

العلاقة: LUNG CANCER; J02174; OAK-2023-02241; OAK-2023-02242; OAK-2023-02243; OAK-2023-02244; OAK-2023-02245; OAK-2023-02246; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195937Test; https://www.sciencedirect.com/science/article/pii/S0169500223007511Test; T202304087; LUNG CANCER, Vol.180 : 107213, 2023-06

الإتاحة: https://doi.org/10.1016/j.lungcan.2023.107213Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195937Test
https://www.sciencedirect.com/science/article/pii/S0169500223007511Test

View record in BASE

5

دورية أكاديمية

Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non-Small Cell Lung Cancer

المساهمون: Sang Hoon Lee, Eun Young Kim, Jung Min Han, Gyoonhee Han, Yoon Soo Chang, Kim, Eun Young

مصطلحات موضوعية: Amino Acids / pharmacology, Amino Acids / therapeutic use, Animals, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, Cell Line, Tumor, Cell Proliferation, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mammals / metabolism, Mechanistic Target of Rapamycin Complex 1 / metabolism, Mechanistic Target of Rapamycin Complex 1 / pharmacology, Mice, Mitogen-Activated Protein Kinase Kinases / pharmacology, Mitogen-Activated Protein Kinase Kinases / therapeutic use, Protein Kinase Inhibitors / therapeutic use, BC-LI-0186, LARS1, Non-small cell lung cancer, Trametinib, mTORC1

العلاقة: CANCER RESEARCH AND TREATMENT; J00453; OAK-2023-02139; OAK-2023-02140; OAK-2023-02141; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195578Test; T202303868; CANCER RESEARCH AND TREATMENT, Vol.55(3) : 851-864, 2023-06

الإتاحة: https://doi.org/10.4143/crt.2022.1527Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195578Test

View record in BASE

النص الكامل

6

دورية أكاديمية

Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

المساهمون: Seung Yeon Oh, You Won Lee, Eun Ji Lee, Jae Hwan Kim, YoungJoon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun, Lim, Sun Min

مصطلحات موضوعية: Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, Cell Line, Tumor, Drug Resistance, Neoplasm / genetics, ErbB Receptors, Humans, Immunoconjugates* / therapeutic use, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mutation, Protein Kinase Inhibitors / pharmacology, Protein Kinase Inhibitors / therapeutic use, Proto-Oncogene Proteins c-met

العلاقة: CLINICAL CANCER RESEARCH; J00564; OAK-2023-01589; OAK-2023-01590; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195372Test; https://aacrjournals.org/clincancerres/article/29/1/221/711969Test; T202303016; CLINICAL CANCER RESEARCH, Vol.29(1) : 221-232, 2023-01

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-2180Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195372Test
https://aacrjournals.org/clincancerres/article/29/1/221/711969Test

View record in BASE

النص الكامل

7

دورية أكاديمية

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

المساهمون: Melissa L Johnson, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Konstantin Laktionov, Sang-We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng-Ta Yang, Luiz Henrique Araujo, Haruhiro Saito, Niels Reinmuth, Xiaojin Shi, Lynne Poole, Solange Peters, Edward B Garon, Tony Mok, POSEIDON investigators, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Carcinoma, Non-Small-Cell Lung* / pathology, Humans, Lung Neoplasms* / pathology

العلاقة: JOURNAL OF CLINICAL ONCOLOGY; J01331; OAK-2023-01376; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195297Test; T202302901; JOURNAL OF CLINICAL ONCOLOGY, Vol.41(6) : 1213-1227, 2023-02

الإتاحة: https://doi.org/10.1200/JCO.22.00975Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195297Test

View record in BASE

8

دورية أكاديمية

Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications

المساهمون: Byoung Chul Cho, Allison Simi, Joshua Sabari, Smruthi Vijayaraghavan, Sheri Moores, Alexander Spira, Cho, Byoung Chul

مصطلحات موضوعية: Carcinoma, Non-Small-Cell Lung* / pathology, ErbB Receptors, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mutation, Protein Kinase Inhibitors / therapeutic use, Exon 20 insertions, Immune cell-directing activity, Ligand blocking, Resistance pathways, Targeted therapy

العلاقة: CLINICAL LUNG CANCER; J03603; OAK-2023-01381; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195300Test; T202302904; CLINICAL LUNG CANCER, Vol.24(2) : 89-97, 2023-03

الإتاحة: https://doi.org/10.1016/j.cllc.2022.11.004Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195300Test

View record in BASE

9

دورية أكاديمية

A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation

المساهمون: Youngjoo Lee, Hye Ryun Kim, Min Hee Hong, Ki Hyeong Lee, Keon Uk Park, Geon Kook Lee, Hyae Young Kim, Soo-Hyun Lee, Kun Young Lim, Sung Jin Yoon, Byoung Chul Cho, Ji-Youn Han, Kim, Hye Ryun

العلاقة: CANCER; J00434; OAK-2023-01377; OAK-2023-01378; OAK-2023-01379; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195298Test; T202302902; CANCER, Vol.129(3) : 405-414, 2023-02

الإتاحة: https://doi.org/10.1002/cncr.34553Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195298Test

View record in BASE

النص الكامل

10

دورية أكاديمية

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing

المساهمون: Beung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim, Kim, Hye Ryun

مصطلحات موضوعية: Antineoplastic Agents* / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, Female, High-Throughput Nucleotide Sequencing, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Male, Middle Aged, Mutation, Retrospective Studies, Brain metastasis, HER2 mutation, Lung neopla는

وصف الملف: application/pdf

العلاقة: CANCER RESEARCH AND TREATMENT; J00453; OAK-2023-01088; OAK-2023-01089; OAK-2023-01090; https://ir.ymlib.yonsei.ac.kr/handle/22282913/194217Test; T202302703; CANCER RESEARCH AND TREATMENT, Vol.55(2) : 488-497, 2023-04

الإتاحة: https://doi.org/10.4143/crt.2022.359Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194217Test

View record in BASE

النص الكامل

تنقيح النتائج